Natural History Study of Patients With MPS IIIA

NCT02746341 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2021-08-31

No results posted yet for this study

Summary

Evaluate the clinical progression in patients with MPS IIIA who are untreated with any investigational product and to obtain standardized assessments: neurocognitive, behavioral, sleep-wake habits and effect of MPS IIIA on the quality of life of patients and their families.

Conditions

  • Mucopolysaccharidosis IIIA

Sponsors & Collaborators

  • LYSOGENE

    lead INDUSTRY

Eligibility

Min Age
0 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2019-05-31
Completion
2019-05-31

Countries

  • Brazil
  • France
  • Germany
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02746341 on ClinicalTrials.gov